This study identifies RNF10 as a critical regulator of cardiac mitophagy, suggesting that targeting cardiac RNF10 may represent a therapeutic strategy for treating cardiac pathologies.
A cardiac-specific Miro1 knockout mouse model is generated to investigate how cardiomyocyte-Miro1 deficiency affects cardiac and mitochondrial structure-function and identifies Miro1 as a regulator of mitochondrial morphology.
Sarah Kassab, Zainab Albalawi, Asim M Khojah et al.· Journal of Molecular and Cel...· 0 citations
The findings of this study highlight RNF128 as a novel therapeutic target for heart failure, linking ubiquitination-dependent protein regulation to calcium handling in cardiomyocytes.
AAV-mediated overexpression of Cldn5 significantly protected the heart against ischemic injury by reducing infarct size, preserving mitochondrial number, preserving mitochondrial number, decreasing ADP/ATP ratio and mitochondrial ROS production, and enhancing the signal of energy metabolism and mitochondrial biogenesis...
Xia Yu, Bai-He Chen, Li-Jun Wang et al.· Biochimica et Biophysica Act...· 0 citations
Fibroblast-derived myocilin is identified as a fibroblast-derived mediator that drives cardiomyocyte mitochondrial dysfunction and ROS production in HF and a fibroblast–cardiomyocyte signaling axis in which myocilin disrupts cardiomyocyte metabolic homeostasis is identified.
Background: Protein quality control (PQC) is critical for maintaining sarcomere structure and function in cardiomyocytes. Mutations in PQC pathway proteins, namely CRYAB-R120G (arginine to glycine at position 120) and BAG3-P209L (proline to lysine at position 209) induce protein aggregates and cardiomyopathy in humans....
David R. Rawnsley, Moydul Islam, Chen Zhao et al.· Circulation Research· 0 citations